Systemic lupus erythematosus is associated with increased risk of mortality and acute kidney injury in patients with COVID-19 hospitalization: Insights from a National Inpatient Sample analysis.
Anum AkhlaqSameen AamerKhawaja Muthammir HasanTaimur Sohail MuzammilAmir Humza SohailMohammed A QuaziMuhammad Salman KhanAbu Baker SheikhPublished in: Lupus (2024)
COVID-19 patients with SLE are at an increased mortality risk, especially in the younger age group, and a higher incidence of acute kidney injury requiring dialysis. The elevated risk of adverse outcomes underscores the vulnerability of SLE patients to COVID-19. These findings emphasize the importance of special precautions and patient education for individuals with SLE to mitigate the risks associated with COVID-19.
Keyphrases
- systemic lupus erythematosus
- sars cov
- end stage renal disease
- disease activity
- coronavirus disease
- acute kidney injury
- chronic kidney disease
- peritoneal dialysis
- ejection fraction
- risk factors
- quality improvement
- healthcare
- cardiac surgery
- palliative care
- prognostic factors
- climate change
- cardiovascular events
- mental health
- patient reported outcomes
- respiratory syndrome coronavirus
- cardiovascular disease
- risk assessment
- human health
- coronary artery disease
- data analysis